SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+8.83%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$525M
AUM Growth
+$525M
(+20%)
Cap. Flow
+$47.5M
Cap. Flow
% of AUM
9.04%
Top 10 Holdings %
Top 10 Hldgs %
56.68%
Holding
32
New
4
Increased
11
Reduced
14
Closed
3
Top Buys
| 1 |
Becton Dickinson
BDX
|
$30.5M |
| 2 |
Pfizer
PFE
|
$21.8M |
| 3 |
Gilead Sciences
GILD
|
$21M |
| 4 |
Merck
MRK
|
$15.1M |
| 5 |
Centene
CNC
|
$11.6M |
Top Sells
| 1 |
Agilent Technologies
A
|
$17.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$11.2M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$10.5M |
| 4 |
Medtronic
MDT
|
$9.68M |
| 5 |
Revvity
RVTY
|
$8.43M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rigel Pharmaceuticals
RIGL
$697M
| $5.6M | 1.06% |
1,598,649
+233,363
| +17% | +$817K |
|
27
Johnson & Johnson
JNJ
$427B
| $5.51M | 1.05% |
35,000
-22,116
| -39% | -$3.48M |
|
28
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.85M | 0.73% |
29,615
+10,124
| +52% | +$1.32M |
|
29
Novavax
NVAX
$1.21B
| $1.28M | 0.24% |
+11,500
| New | +$1.28M |
|
|
30
Agilent Technologies
A
$35.7B
| – | – |
-169,734
| Closed | -$17.1M |
|
|
CLVS
31
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-156,969
| Closed | -$915K |
|
|
CERN
32
DELISTED
Cerner Corp
CERN
| – | – |
-26,122
| Closed | -$1.89M |
|